Control group:Danggui Shaoyao powder granule simulant

2 trials

Sponsors

Shuguang Hospital affiliated to Shanghai University of TCM

Conditions

Nonalcoholic fatty liver disease

Unknown Phase

Study for effect of classic prescription Danggui Shaoyao Powder in the treatment of Wet-stasis syndrome Non-alcoholic Fatty Liver Disease

Active, not recruitingChiCTR2000029144

Shuguang Hospital affiliated to Shanghai University of TCMNonalcoholic fatty liver disease

Start: 2020-02-15Updated: 2020-01-20

Study for effect of classic prescription Danggui Shaoyao Powder in the treatment of Wet-stasis syndrome Non-alcoholic Fatty Liver Disease

Active, not recruitingITMCTR2000002925

Shuguang Hospital affiliated to Shanghai University of TCMNonalcoholic fatty liver disease

Start: 2020-02-15Updated: 2023-02-20

Related Papers

Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial.

2025-11-19

Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial.

2023-04-194 citations